A61K31/473

Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.

Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.

BENZO-HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS

The present invention relates to benzoxazole derivatives having the following Formula (I):

##STR00001##

The compounds of the present invention are found to possess the ability to decrease PD-L1 level, suggesting that the compounds of the invention can be used in cancer immunotherapy and treatment or prevention of sepsis or septic shock.

BENZO-HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS

The present invention relates to benzoxazole derivatives having the following Formula (I):

##STR00001##

The compounds of the present invention are found to possess the ability to decrease PD-L1 level, suggesting that the compounds of the invention can be used in cancer immunotherapy and treatment or prevention of sepsis or septic shock.

BENZO-HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS

The present invention relates to benzoxazole derivatives having the following Formula (I):

##STR00001##

The compounds of the present invention are found to possess the ability to decrease PD-L1 level, suggesting that the compounds of the invention can be used in cancer immunotherapy and treatment or prevention of sepsis or septic shock.

Small molecule inhibitors of viral protein interactions with human t-RNA

Disclosed herein are compounds, compositions and methods of their use to treat HIV/AIDS disease in a subject in need thereof, wherein the compositions comprise small molecule inhibitors that inhibit viral preparation or viral recruitment of human tRNA3Lys.

Small molecule inhibitors of viral protein interactions with human t-RNA

Disclosed herein are compounds, compositions and methods of their use to treat HIV/AIDS disease in a subject in need thereof, wherein the compositions comprise small molecule inhibitors that inhibit viral preparation or viral recruitment of human tRNA3Lys.

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
20220047541 · 2022-02-17 ·

Pharmaceutical compositions and methods for treating and/or preventing and/or control of Parkinson's Disease and/or related symptoms in a patient.

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
20220047541 · 2022-02-17 ·

Pharmaceutical compositions and methods for treating and/or preventing and/or control of Parkinson's Disease and/or related symptoms in a patient.

BENZOQUINOLONE INHIBITORS OF VMAT2
20170246159 · 2017-08-31 ·

The present invention relates to new benzoquinolone inhibitors of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.

##STR00001##